Jane A. Foster - Publications

McMaster University, Hamilton, ON, Canada 

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Luo OD, Kwiecien-Delaney B, Martin P, Foster JA, Sidor MM. The effect of early life immune challenge on adult forced swim test performance and hippocampal neurogenesis. Journal of Neuroimmunology. 354: 577530. PMID 33744708 DOI: 10.1016/j.jneuroim.2021.577530  0.685
2020 Uher R, Frey BN, Quilty LC, Rotzinger S, Blier P, Foster JA, Müller DJ, Ravindran AV, Soares CN, Turecki G, Parikh SV, Milev R, MacQueen G, Lam RW, Kennedy SH, et al. Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 81. PMID 32558407 DOI: 10.4088/Jcp.20M13229  0.316
2020 Phillips JL, Jaworska N, Kamler E, Bhat V, Blier J, Foster JA, Hassel S, Ho K, McMurray L, Milev R, Moazamigoudarzi Z, Placenza FM, Richard-Devantoy S, Rotzinger S, Turecki G, et al. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. Bmc Psychiatry. 20: 268. PMID 32487236 DOI: 10.1186/S12888-020-02672-3  0.319
2020 Dunlop K, Rizvi SJ, Kennedy SH, Hassel S, Strother SC, Harris JK, Zamyadi M, Arnott SR, Davis AD, Mansouri F, Schulze L, Ceniti AK, Lam RW, Milev R, Rotzinger S, ... Foster JA, et al. Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32349119 DOI: 10.1038/S41386-020-0688-X  0.342
2019 Yrondi A, Fiori LM, Frey BN, Lam RW, MacQueen GM, Milev R, Müller DJ, Foster JA, Kennedy SH, Turecki G. Association between side effects and blood microRNA expression levels and their targeted pathways in patients with major depressive disorder treated by a selective serotonin reuptake inhibitor, escitalopram: a CAN-BIND-1 report. The International Journal of Neuropsychopharmacology. PMID 31819986 DOI: 10.1093/Ijnp/Pyz066  0.335
2019 Caspani G, Kennedy S, Foster JA, Swann J. Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microbial Cell (Graz, Austria). 6: 454-481. PMID 31646148 DOI: 10.15698/Mic2019.10.693  0.345
2019 Ju C, Fiori LM, Belzeaux R, Theroux JF, Chen GG, Aouabed Z, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, ... ... Foster JA, et al. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. Translational Psychiatry. 9: 254. PMID 31594917 DOI: 10.1038/S41398-019-0589-0  0.318
2019 Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Giacobbe P, Hall GB, Harkness KL, Hassel S, Ismail Z, et al. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 80. PMID 30840787 DOI: 10.4088/Jcp.18M12202  0.538
2019 MacQueen GM, Hassel S, Arnott SR, Jean A, Bowie CR, Bray SL, Davis AD, Downar J, Foster JA, Frey BN, Goldstein BI, Hall GB, Harkness KL, Harris J, Lam RW, et al. The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols Journal of Psychiatry & Neuroscience : Jpn. 44: 1-14. PMID 30840428 DOI: 10.1503/Jpn.180036  0.518
2019 Maciukiewicz M, Marshe V, Hauschild A, Foster JA, Rotzinger S, Kennedy JL, Kennedy SH, Müller DJ, Geraci J. GWAS-BASED MACHINE LEARNING APPROACH TO PREDICT DULOXETINE RESPONSE AND REMISSION IN MAJOR DEPRESSIVE DISORDER European Neuropsychopharmacology. 29: S843. DOI: 10.1016/J.Euroneuro.2017.08.110  0.311
2019 Suh JS, Minuzzi L, Raamana P, Strother SC, MacQueen GM, Hassel S, Alders G, Arnott S, Davis AD, Harris JK, Sharma GB, Zamyadi M, Blier P, Downar J, Farzan F, ... Foster J, et al. F107. Cortical Thickness Features Differentiate 16-Week Antidepressant Response Profiles in Major Depressive Disorder Biological Psychiatry. 85: S254. DOI: 10.1016/J.Biopsych.2019.03.644  0.529
2018 Maciukiewicz M, Marshe VS, Hauschild AC, Foster JA, Rotzinger S, Kennedy JL, Kennedy SH, Müller DJ, Geraci J. GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. Journal of Psychiatric Research. 99: 62-68. PMID 29407288 DOI: 10.1016/J.Jpsychires.2017.12.009  0.304
2017 Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiology of Stress. 7: 124-136. PMID 29276734 DOI: 10.1016/j.ynstr.2017.03.001  0.314
2017 Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Kennedy JL, Rotzinger S, Foster JA, Kennedy SH, Müller DJ. Genome-wide association studies of placebo and duloxetine response in major depressive disorder. The Pharmacogenomics Journal. PMID 28696415 DOI: 10.1038/Tpj.2017.29  0.301
2017 Harkness KL, Foster J, Li M, MacQueen G, Milev R, Frey B, Kennedy S. Childhood maltreatment and markers of neuroinflammation predict response to anti-depressant treatment in adults with major depressive disorder Psychoneuroendocrinology. 83: 73. DOI: 10.1016/J.Psyneuen.2017.07.435  0.339
2017 Hassel S, Davis A, Hall G, Foster J, Harkness K, Harris J, Zamyadi M, Arnott S, Alders G, Rotzinger S, Strother S, Kennedy S, MacQueen G. 754. Inflammatory Markers as Mediators of the Association between Early Life Adversity and Hippocampal Volume in Adult Patients with depression: Findings from Phase 1 of the CAN-BIND Study Biological Psychiatry. 81: S306. DOI: 10.1016/J.Biopsych.2017.02.821  0.528
2016 Slyepchenko A, Maes M, Jacka FN, Köhler CA, Barichello T, McIntyre RS, Berk M, Grande I, Foster JA, Vieta E, Carvalho AF. Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities. Psychotherapy and Psychosomatics. 86: 31-46. PMID 27884012 DOI: 10.1159/000448957  0.339
2016 Tatham EL, Ramasubbu R, Gaxiola-Valdez I, Cortese F, Clark D, Goodyear B, Foster J, Hall GB. White matter integrity in major depressive disorder: Implications of childhood trauma, 5-HTTLPR and BDNF polymorphisms. Psychiatry Research. 253: 15-25. PMID 27261564 DOI: 10.1016/J.Pscychresns.2016.04.014  0.536
2016 Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Geraci J, Giacobbe P, et al. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. Bmc Psychiatry. 16: 105. PMID 27084692 DOI: 10.1186/S12888-016-0785-X  0.536
2016 Jaworska N, MacMaster FP, Foster J, Ramasubbu R. The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study. Bmc Psychiatry. 16: 61. PMID 26976307 DOI: 10.1186/S12888-016-0777-X  0.344
2016 Ramasubbu R, Burgess A, Gaxiola-Valdez I, Cortese F, Clark D, Kemp A, Goodyear B, Macqueen G, Bech-Hansen NT, Foster J, Diwadkar VA. Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5-HTTLPR-S/Lg polymorphisms. Human Psychopharmacology. PMID 26879101 DOI: 10.1002/Hup.2521  0.341
2016 Lai JK, Lerch JP, Doering LC, Foster JA, Ellegood J. Regional Brain Volumes Changes in Adult Male FMR1-KO Mouse on the FVB Strain. Neuroscience. PMID 26794591 DOI: 10.1016/j.neuroscience.2016.01.021  0.307
2016 Fonseka TM, Wen XY, Foster JA, Kennedy SH. Zebrafish models of major depressive disorders. Journal of Neuroscience Research. 94: 3-14. PMID 26452974 DOI: 10.1002/Jnr.23639  0.325
2015 Zhou L, Foster JA. Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatric Disease and Treatment. 11: 715-23. PMID 25834446 DOI: 10.2147/NDT.S61997  0.301
2015 Rilett KC, Friedel M, Ellegood J, MacKenzie RN, Lerch JP, Foster JA. Loss of T cells influences sex differences in behavior and brain structure. Brain, Behavior, and Immunity. 46: 249-60. PMID 25725160 DOI: 10.1016/j.bbi.2015.02.016  0.32
2015 Luna RA, Foster JA. Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Current Opinion in Biotechnology. 32: 35-41. PMID 25448230 DOI: 10.1016/j.copbio.2014.10.007  0.322
2014 Lai JK, Sobala-Drozdowski M, Zhou L, Doering LC, Faure PA, Foster JA. Temporal and spectral differences in the ultrasonic vocalizations of fragile X knock out mice during postnatal development. Behavioural Brain Research. 259: 119-30. PMID 24211451 DOI: 10.1016/j.bbr.2013.10.049  0.323
2014 Sidor MM, Halgren CR, Foster JA. The impact of early life immune challenge on behavior and microglia during postnatal development Inflammation and Cell Signaling. 1. DOI: 10.14800/Ics.83  0.693
2014 Ramasubbu R, Clark D, Kondru N, Kemp A, Foster J, Goodyear B. P.1.i.034 The impact of 5-HTTLPR and BDNF Val66Met on heterogeneity of intrinsic connectivity of amygdala in major depressive disorder European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70503-6  0.337
2013 Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences. 36: 305-12. PMID 23384445 DOI: 10.1016/j.tins.2013.01.005  0.355
2013 Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, Versalovic J, Verdu EF, Dinan TG, Hecht G, Guarner F. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes. 4: 17-27. PMID 23202796 DOI: 10.4161/Gmic.22973  0.316
2012 Amath A, Foster JA, Sidor MM. Developmental alterations in CNS stress-related gene expression following postnatal immune activation. Neuroscience. 220: 90-9. PMID 22732504 DOI: 10.1016/J.Neuroscience.2012.06.037  0.696
2012 Sankar A, MacKenzie RN, Foster JA. Loss of class I MHC function alters behavior and stress reactivity. Journal of Neuroimmunology. 244: 8-15. PMID 22245287 DOI: 10.1016/j.jneuroim.2011.12.025  0.316
2011 Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M. Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin. The Journal of Clinical Psychiatry. 72: e1563-9. PMID 22127200 DOI: 10.4088/Jcp.11Com07089  0.343
2011 Neufeld KA, Kang N, Bienenstock J, Foster JA. Effects of intestinal microbiota on anxiety-like behavior. Communicative & Integrative Biology. 4: 492-4. PMID 21966581 DOI: 10.4161/cib.4.4.15702  0.327
2011 Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 23: 255-64, e119. PMID 21054680 DOI: 10.1111/j.1365-2982.2010.01620.x  0.37
2010 Sidor MM, Amath A, MacQueen G, Foster JA. A developmental characterization of mesolimbocortical serotonergic gene expression changes following early immune challenge. Neuroscience. 171: 734-46. PMID 20816924 DOI: 10.1016/J.Neuroscience.2010.08.060  0.683
2010 Roullet FI, Wollaston L, Decatanzaro D, Foster JA. Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience. 170: 514-22. PMID 20603192 DOI: 10.1016/J.Neuroscience.2010.06.069  0.317
2010 Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, Lu J, Khan WI, Corthesy-Theulaz I, Cherbut C, Bergonzelli GE, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 139: 2102-2112.e1. PMID 20600016 DOI: 10.1053/j.gastro.2010.06.063  0.342
2010 Sidor MM, Rilett K, Foster JA. Validation of an automated system for measuring anxiety-related behaviours in the elevated plus maze. Journal of Neuroscience Methods. 188: 7-13. PMID 20100514 DOI: 10.1016/J.Jneumeth.2010.01.021  0.654
2009 Kolozsi E, Mackenzie RN, Roullet FI, deCatanzaro D, Foster JA. Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. Neuroscience. 163: 1201-10. PMID 19607885 DOI: 10.1016/J.Neuroscience.2009.07.021  0.345
2008 Foster JA, MacQueen G. Neurobiological factors linking personality traits and major depression. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 53: 6-13. PMID 18286867 DOI: 10.1177/070674370805300103  0.343
2008 Chun S, McEvilly R, Foster JA, Sakic B. Proclivity to self-injurious behavior in MRL-lpr mice: implications for autoimmunity-induced damage in the dopaminergic system. Molecular Psychiatry. 13: 1043-53. PMID 17768421 DOI: 10.1038/sj.mp.4002078  0.332
2005 Bryceson YT, Foster JA, Kuppusamy SP, Herkenham M, Long EO. Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. Journal of Neuroimmunology. 161: 177-82. PMID 15748957 DOI: 10.1016/j.jneuroim.2004.11.018  0.572
2004 Foster JA, Puchowicz MJ, McIntyre DC, Herkenham M. Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. The Journal of Comparative Neurology. 476: 91-102. PMID 15236469 DOI: 10.1002/cne.20197  0.553
2002 Foster JA, Quan N, Stern EL, Kristensson K, Herkenham M. Induced neuronal expression of class I major histocompatibility complex mRNA in acute and chronic inflammation models. Journal of Neuroimmunology. 131: 83-91. PMID 12458039 DOI: 10.1016/S0165-5728(02)00258-8  0.654
2002 Proescholdt MG, Chakravarty S, Foster JA, Foti SB, Briley EM, Herkenham M. Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience. 112: 731-49. PMID 12074914 DOI: 10.1016/S0306-4522(02)00048-9  0.55
Show low-probability matches.